missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Ocrelizumab Recombinant Human Monoclonal Antibody, Invitrogen™
Human Recombinant Monoclonal Antibody
Brand: Invitrogen MA541829
325.34 EUR valid until 2025-03-21
Use promo code "24111" to get your promotional price.
Alert:
To receive the discount customers must purchase three of the same product at list price in a single order to receive 33.33% discount. There is no limit to the multiples of 3 that customers can buy. Use promo code ”24111” to get your promotional price
Description
Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 °C for one week. Store at -20 to -80 °C for twelve months from the date of receipt.
Ocrelizumab is a CD20-directed cytolytic antibody indicated for the treatment of patients with relapsing or primary progressive forms of multiple sclerosis. It is a second-generation recombinant humanized monoclonal IgG1 antibody that selectively targets the B lymphocytes that express the CD20 antigen. As a humanized molecule, ocrelizumab is expected to be less immunogenic with repeated infusions which improves the benefit-to-risk profile for patients with relapsing or progressive forms of MS.
Specifications
| Ocrelizumab | |
| Recombinant Monoclonal | |
| Unconjugated | |
| 2H7; CD20; MS4A1 | |
| Human MS4A1/CD20 | |
| 100 μg | |
| Primary | |
| -20° C, Avoid Freeze/Thaw Cycles | |
| Liquid | |
| Chemical |
| ELISA, SDS-Page | |
| 4.13 mg/mL | |
| PBS with no preservative; pH 7.5 | |
| Human | |
| Protein A | |
| RUO | |
| Chemical | |
| Antibody | |
| IgG1 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Ocrelizumab Recombinant Human Monoclonal Antibody, Invitrogen™ > 100 μg; Unconjugated
Spot an opportunity for improvement?Share a Content Correction